| Literature DB >> 31481111 |
Ashraf Moini1,2, Reihaneh Pirjani3, Maryam Rabiei2, Maryam Nurzadeh2, Mahdi Sepidarkish4, Reihaneh Hosseini2, Ladan Hosseini5.
Abstract
BACKGROUND: The incidence of Cesarean has increased in recent years. The purpose of this study is to evaluate the effect of cesarean section on ovarian reserve. This is a prospective cohort study from January 2016 to November 2017. Inclusion criteria included singleton primigravid pregnant women whose gestational age was above 37 weeks. Exclusion criteria included history of infertility, pelvic surgery, underlying chronic diseases, any adverse pregnancy outcome and postpartum complication in current pregnancy and hormonal medication within six months of delivery. Anti-Mullerian hormone was measured at the admission time for delivery. The type of delivery was determined based on obstetrics indications. Six months after delivery, antral follicle count was performed and anti-Mullerian hormone was measured again. RESULT(S): First blood sample was taken from 730 women. After excluding 550 women, the second blood sample was taken from 180 participants. The mean of first anti-Mullerian hormone in women with cesarean and vaginal delivery were 1.01 ng/mL (95% CI 0.82 to 1.18) and 1.18 ng/mL (95% CI 0.96 to 1.40) respectively (P = 0.211). The mean of second anti-Mullerian hormone in women with cesarean and vaginal delivery were 4.77 ng/mL (95% CI:3.91 to 5.63) and 4.92 ng/mL (95% CI: 4.01 to 5.82) respectively (P = 0.818). No statistically significant difference existed in total AFC between cesarean and vaginal delivery groups (MD: 0.41, 95% CI: - 1.05 to 1.89, P = 0.576).Entities:
Keywords: Anti-Mullerian hormone; Antral follicle count; Caesarean section; Delivery mode; Ovarian reserve
Mesh:
Substances:
Year: 2019 PMID: 31481111 PMCID: PMC6720941 DOI: 10.1186/s13048-019-0551-z
Source DB: PubMed Journal: J Ovarian Res ISSN: 1757-2215 Impact factor: 4.234
Fig. 1Flow diagram of pregnant women recruitment
Patients’ demographics, baseline AMH, and AFC
| Variable | Women with CS ( | Women with VD ( | |
|---|---|---|---|
| Age | 27.42 (5.42) | 26.20 (4.76) | 0.112 |
| BMI | 24.03 (4.20) | 24.03 (3.99) | 0.997 |
| Gestational age at delivery | 39.03 (3.90) | 38.89 (1.07) | 0.997 |
| Neonate weight | 3296.33 (407.02) | 3173.33 (487.35) | 0.067 |
| AFC (left ovary) | 5.66 (2.90) | 5.52 (2.90) | 0.754 |
| AFC (right ovary) | 5.83 (2.66) | 5.55 (2.42) | 0.471 |
| AMH1 | 1.01 (0.88) | 1.18 (1.01) | 0.211 |
| AMH2 | 4.77 (4.20) | 4.92 (4.19) | 0.818 |
| AMH2− AMH1 | 3.80 (3.74) | 3.73 (3.62) | 0.897 |
| Neonate Sex | |||
| Male | 44 (46.3) | 52 (38.8) | 0.046 |
| Female | 51 (53.7) | 33 (61.2) | |
| Breastfeeding | |||
| Yes | 69 (72.6) | 63 (74.1) | 0.822 |
| No | 26 (27.4) | 22 (25.9) | |
| Postpartum menstruation | |||
| Yes | 68 (71.6) | 57 (67.1) | 0.511 |
| No | 27 (28.4) | 28 (32.9) | |
1At the beginning of study
2After six months
Fig. 2The mean of AMH at the beginning of study and after six months between cesarean section and natural vaginal delivery